drugset / Trial / NCT02802228
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This placebo-controlled study will assess the safety and efficacy of a 90-day course of treatment with ifetroban for portal hypertension in cirrhotic patients
Timeline
- Start
- 2017-03-06
- Primary completion
- 2018-07-17
- Completion
- 2018-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ifetroban | Small molecule | — | Intravenous |